Metastatic and locally aggressive BCC: Current treatment options

Abstract The treatment of locally advanced and metastatic BCC presents a significant clinical challenge. Treatment options have evolved recently to include the use of hedgehog inhibitors Vismodigib and Sonidigib and immunotherapy with Cemiplimab.

Guardado en:

Detalles Bibliográficos
Autores principales:	Máire‐Caitlín Casey, Roisín Pollock, Rachel H Enright, James Paul O'Neill, Neville Shine, Paul Sullivan, Fiachra T Martin, Barry O'Sullivan
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	basal cell carcinoma locally aggressive BCC metastatic BCC Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/473be61cdd9644e4a7a8012eec9a4c74
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:473be61cdd9644e4a7a8012eec9a4c74
record_format	dspace
spelling	oai:doaj.org-article:473be61cdd9644e4a7a8012eec9a4c742021-12-02T07:55:57ZMetastatic and locally aggressive BCC: Current treatment options2050-090410.1002/ccr3.4965https://doaj.org/article/473be61cdd9644e4a7a8012eec9a4c742021-10-01T00:00:00Zhttps://doi.org/10.1002/ccr3.4965https://doaj.org/toc/2050-0904Abstract The treatment of locally advanced and metastatic BCC presents a significant clinical challenge. Treatment options have evolved recently to include the use of hedgehog inhibitors Vismodigib and Sonidigib and immunotherapy with Cemiplimab.Máire‐Caitlín CaseyRoisín PollockRachel H EnrightJames Paul O'NeillNeville ShinePaul SullivanFiachra T MartinBarry O'SullivanWileyarticlebasal cell carcinomalocally aggressive BCCmetastatic BCCMedicineRMedicine (General)R5-920ENClinical Case Reports, Vol 9, Iss 10, Pp n/a-n/a (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	basal cell carcinoma locally aggressive BCC metastatic BCC Medicine R Medicine (General) R5-920
spellingShingle	basal cell carcinoma locally aggressive BCC metastatic BCC Medicine R Medicine (General) R5-920 Máire‐Caitlín Casey Roisín Pollock Rachel H Enright James Paul O'Neill Neville Shine Paul Sullivan Fiachra T Martin Barry O'Sullivan Metastatic and locally aggressive BCC: Current treatment options
description	Abstract The treatment of locally advanced and metastatic BCC presents a significant clinical challenge. Treatment options have evolved recently to include the use of hedgehog inhibitors Vismodigib and Sonidigib and immunotherapy with Cemiplimab.
format	article
author	Máire‐Caitlín Casey Roisín Pollock Rachel H Enright James Paul O'Neill Neville Shine Paul Sullivan Fiachra T Martin Barry O'Sullivan
author_facet	Máire‐Caitlín Casey Roisín Pollock Rachel H Enright James Paul O'Neill Neville Shine Paul Sullivan Fiachra T Martin Barry O'Sullivan
author_sort	Máire‐Caitlín Casey
title	Metastatic and locally aggressive BCC: Current treatment options
title_short	Metastatic and locally aggressive BCC: Current treatment options
title_full	Metastatic and locally aggressive BCC: Current treatment options
title_fullStr	Metastatic and locally aggressive BCC: Current treatment options
title_full_unstemmed	Metastatic and locally aggressive BCC: Current treatment options
title_sort	metastatic and locally aggressive bcc: current treatment options
publisher	Wiley
publishDate	2021
url	https://doaj.org/article/473be61cdd9644e4a7a8012eec9a4c74
work_keys_str_mv	AT mairecaitlincasey metastaticandlocallyaggressivebcccurrenttreatmentoptions AT roisinpollock metastaticandlocallyaggressivebcccurrenttreatmentoptions AT rachelhenright metastaticandlocallyaggressivebcccurrenttreatmentoptions AT jamespauloneill metastaticandlocallyaggressivebcccurrenttreatmentoptions AT nevilleshine metastaticandlocallyaggressivebcccurrenttreatmentoptions AT paulsullivan metastaticandlocallyaggressivebcccurrenttreatmentoptions AT fiachratmartin metastaticandlocallyaggressivebcccurrenttreatmentoptions AT barryosullivan metastaticandlocallyaggressivebcccurrenttreatmentoptions
_version_	1718399099206631424

Metastatic and locally aggressive BCC: Current treatment options

Ejemplares similares